Biomatics Capital
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Portal
Select Page

Neuroscience is Taking the Spotlight at Xconomy’s Bay Area Xchange

by bizlift | Nov 11, 2019 | BlackThorn Press Coverage, Portfolio Media Coverage

TechCrunch: Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders

by bizlift | Jun 17, 2019 | BlackThorn Press Coverage, Portfolio Media Coverage

Yale News: Marriage of imaging and genetics opens new view of brain function

by bizlift | Aug 16, 2018 | BlackThorn Press Coverage, Portfolio Media Coverage

BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist

by bizlift | Jun 6, 2018 | BlackThorn Press Coverage, Portfolio Media Coverage

FierceBiotech: Pivotal moments for this year’s Fierce 15 winners

by bizlift | Sep 28, 2017 | BlackThorn Press Coverage, Portfolio Media Coverage

FierceBiotech: FierceBiotech’s 2017 Fierce 15

by bizlift | Sep 26, 2017 | BlackThorn Press Coverage, Portfolio Media Coverage

« Older Entries
© Copyright 2025 Biomatics Capital